IperionX Limited Sponsored ADR (NASDAQ:IPX - Get Free Report) shares hit a new 52-week low during mid-day trading on Wednesday. The company traded as low as $17.38 and last traded at $17.8940, with a volume of 51927 shares traded. The stock had previously closed at $18.30.
Wall Street Analyst Weigh In
IPX has been the topic of several analyst reports. Roth Capital set a $53.00 price objective on shares of IperionX in a research note on Wednesday, August 5th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of IperionX in a research report on Friday, July 17th. Jefferies Financial Group began coverage on IperionX in a report on Wednesday, September 2nd. They set a "buy" rating and a $26.00 target price on the stock. B. Riley Financial reduced their price target on IperionX from $52.00 to $34.00 and set a "buy" rating on the stock in a research report on Wednesday. Finally, BTIG Research increased their price target on IperionX from $40.00 to $55.00 and gave the company a "buy" rating in a research note on Friday, June 5th. Six investment analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, IperionX presently has a consensus rating of "Moderate Buy" and a consensus price target of $42.00.
Get Our Latest Research Report on IPX
IperionX Stock Performance
The company has a debt-to-equity ratio of 0.03, a current ratio of 4.03 and a quick ratio of 4.00. The stock's 50-day moving average price is $21.66 and its 200-day moving average price is $28.04.
IperionX (NASDAQ:IPX - Get Free Report) last posted its quarterly earnings data on Thursday, July 30th. The company reported ($0.50) earnings per share for the quarter. On average, equities research analysts expect that IperionX Limited Sponsored ADR will post -0.18 EPS for the current year.
Insiders Place Their Bets
In other IperionX news, Chairman Todd Hannigan acquired 300,000 shares of the stock in a transaction dated Monday, July 13th. The stock was purchased at an average cost of $3.59 per share, with a total value of $1,077,000.00. Following the transaction, the chairman owned 26,633,334 shares in the company, valued at approximately $95,613,669.06. The trade was a 1.14% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Anastasios Arima acquired 138,720 shares of the company's stock in a transaction dated Friday, July 10th. The stock was acquired at an average cost of $3.58 per share, for a total transaction of $496,617.60. Following the completion of the purchase, the chief executive officer directly owned 12,455,502 shares in the company, valued at $44,590,697.16. This trade represents a 1.13% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have acquired 663,720 shares of company stock worth $2,379,118 in the last ninety days.
Institutional Investors Weigh In On IperionX
Several large investors have recently added to or reduced their stakes in the business. Connective Capital Management LLC acquired a new stake in shares of IperionX in the 2nd quarter valued at about $160,000. GAMMA Investing LLC raised its stake in IperionX by 40.3% during the 2nd quarter. GAMMA Investing LLC now owns 1,681 shares of the company's stock worth $50,000 after buying an additional 483 shares during the period. DLD Asset Management LP acquired a new position in IperionX during the 1st quarter worth approximately $260,000. Private Advisor Group LLC boosted its holdings in IperionX by 69.9% in the first quarter. Private Advisor Group LLC now owns 63,111 shares of the company's stock worth $1,643,000 after acquiring an additional 25,964 shares in the last quarter. Finally, Corigliano Investment Advisers LLC bought a new position in IperionX in the fourth quarter worth approximately $362,000. Institutional investors and hedge funds own 2.76% of the company's stock.
IperionX Company Profile
(
Get Free Report)
IperionX Limited NASDAQ: IPX is a materials technology company focused on developing a low-carbon, fully integrated titanium supply chain in the United States. The company is working to produce titanium metal and titanium products from locally sourced mineral resources, with applications across the aerospace, defense, automotive, medical and consumer industries.
IperionX's flagship asset is the Titan Project in Tennessee, which contains titanium, rare earth and zircon-rich mineral sands.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider IperionX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IperionX wasn't on the list.
While IperionX currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.